About Omnia Biologics
Omnia Biologics is a company based in Rockville (United States) founded in 2001 was acquired by Vigene Biosciences in November 2016.. Omnia Biologics has raised $25.4 million across 2 funding rounds from investors including Vigene Biosciences and Medipost. Omnia Biologics offers products and services including Process Development, Analytical Development, GMP Manufacturing, and Commercial Manufacturing. Omnia Biologics operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omniabio Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.4 M (USD)
in 2 rounds
-
Latest Funding Round
$23.9 M (USD), Series B
May 24, 2022
-
Investors
Vigene Biosciences
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Vigene Biosciences
(Nov 29, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Omnia Biologics
Omnia Biologics offers a comprehensive portfolio of products and services, including Process Development, Analytical Development, GMP Manufacturing, and Commercial Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Optimizes processes for cell and gene therapy production.
Develops assays for quality control in therapies.
Delivers compliant manufacturing for cell therapies.
Supports large-scale therapy production and delivery.
Unlock access to complete
Funding Insights of Omnia Biologics
Omnia Biologics has successfully raised a total of $25.4M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $23.9 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $23.9M
-
First Round
First Round
(22 May 2006)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series B - Omnia Biologics | Valuation | Medipost |
|
| May, 2006 | Amount | Seed - Omnia Biologics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Omnia Biologics
Omnia Biologics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Vigene Biosciences and Medipost. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Research reagents for drug discovery and functional genomics are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Omnia Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Omnia Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omnia Biologics Comparisons
Competitors of Omnia Biologics
Omnia Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omnia Biologics
Frequently Asked Questions about Omnia Biologics
When was Omnia Biologics founded?
Omnia Biologics was founded in 2001 and raised its 1st funding round 5 years after it was founded.
Where is Omnia Biologics located?
Omnia Biologics is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is Omnia Biologics a funded company?
Omnia Biologics is a funded company, having raised a total of $25.4M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on May 22, 2006.
What does Omnia Biologics do?
Omnia Biologics was founded in 2001 in Rockville, United States, focusing on the biologics sector. Non-GMP and GMP facilities were utilized for process development from preclinical stages through Phase III manufacturing. Expertise encompassed adenovirus, lentivirus, retrovirus, AAV, VLP, and other viral platforms. Services included manufacturing, process development, cell and virus banking, and aseptic filling. Orders are no longer accepted, with diversions directed to Vigene Biosciences.
Who are the top competitors of Omnia Biologics?
Omnia Biologics's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Omnia Biologics offer?
Omnia Biologics offers Process Development, Analytical Development, GMP Manufacturing, and Commercial Manufacturing.
Who are Omnia Biologics's investors?
Omnia Biologics has 2 investors. Key investors include Vigene Biosciences, and Medipost.